A biologic or vaccine can be affected if it is kept outside its approved temperature range, and there is often no visible sign that a temperature excursion has affected product quality. This is the core problem that pharmaceutical cold chain warehouse design needs to address. It is not just a warehouse for boxes but part of the product quality and storage-control strategy itself.

This guide takes you through the real elements of designing a compliant cold storage facility from layout and HVAC pharma industry decisions to the temperature mapping work that proves the design holds up.

Why Cold Chain Warehouse Design Is Different

A typical warehouse is measured by the amount of volume it can move and store. But a pharmaceutical cold chain warehouse is measured by something narrower and less forgiving: whether products throughout the qualified storage volume remain within their specified storage conditions.

The most typical range for pharma cold storage design is 2°C to 8°C, which is widely used for many vaccines and temperature-sensitive pharmaceutical products. Some products need stricter controls. Some may require frozen storage, while others may require ultra-cold storage, depending on the approved product requirements. Each of these bands has its own equipment, insulation, and monitoring needs, and often a single warehouse needs to support more than one of them at a time.European Commission

The Regulatory Backbone: GDP

Good Distribution Practice (GDP) provides the regulatory framework that applies to the storage, handling and movement of pharmaceutical products through the supply chain. GDP warehouse design should provide for appropriate temperature monitoring, calibrated sensors traceable to a recognised standard, and alarm systems that can alert responsible personnel when excursions occur. EU GDP requires environmental monitoring equipment to be calibrated at defined intervals, with calibration traceable to national or international standards, and requires appropriate alarm systems for excursions from predefined storage conditions.

GDP typically expects a few things from a warehouse:

• Qualified and monitored storage areas, not only cooled
• Written procedures for what to do in case of a temperature excursion
• Records retained in accordance with applicable regulatory and national retention requirements
• Qualified storage zones that are clearly defined, with segregation applied where storage conditions, product status or risk require it

None of this is by accident. It has to be designed into the facility and then proven through testing before the building is occupied.

Main Elements of Pharmaceutical Cold Chain Warehouse Design

Zoning and Layout

Typically, a vaccine warehouse design calls for multiple temperature zones under one roof: ambient storage for products that do not require refrigeration, a 2-8°C pharmaceutical storage zone for many vaccines and temperature-sensitive pharmaceutical products, and sometimes a separate frozen or ultra-cold zone for specialty products. Each zone needs appropriate environmental control, defined monitoring points, and suitable physical separation so that the conditions in one zone do not adversely affect another.

Loading docks are a special consideration. Products can be particularly susceptible to temperature swings during receiving and shipping, so a well-designed facility may use airlock-style anterooms, dock shelters, rapid doors, temperature-controlled staging or other appropriate measures that restrict the amount of outside air reaching the cold zones when doors are opened.

HVAC and Refrigeration System Design

The chilled zone is one of the most critical parts of the building to get right. For standard 2-8°C storage, refrigeration capacity and air distribution need to maintain the specified range throughout the qualified storage volume without creating localised hot or cold spots. Supply-air temperature and airflow rates should therefore be determined from room loads, racking configuration, door-opening patterns, product sensitivity and qualification requirements rather than from a single fixed design value.

The airflow pattern is as important as the setpoint. The selected supply and return arrangement, combined with controlled airflow, should promote even temperature distribution throughout the storage area rather than creating pockets that are warmer or colder than the rest of the room.

This change is important because pharmaceutical guidance focuses on demonstrating temperature uniformity and identifying areas affected by cooling coils, cold-air streams, heat sources or air-distribution problems rather than prescribing one universal supply-air temperature or airflow arrangement.

Backup Power and Redundancy

A prolonged power outage or refrigeration failure can put temperature-sensitive pharmaceutical products at risk. Good facilities consider backup power, appropriate refrigeration redundancy and battery-backed monitoring systems based on the facility’s risk assessment, and the design should consider how long the building can maintain its temperature range in the event of total power loss.

Temperature Monitoring, Alarms and BMS/EMS Integration

Cold chain performance depends not only on refrigeration but also on how environmental conditions are monitored, recorded and escalated. Monitoring locations should be established using temperature-mapping and qualification results, with calibrated sensors positioned at representative or worst-case locations as appropriate.

Where BMS or EMS platforms are used, their monitoring functions, alarm handling, data retention, backup arrangements and qualification requirements should be clearly defined as part of the facility design and quality strategy.

WHO guidance recommends temperature monitoring devices in temperature-controlled rooms, cold rooms and freezer rooms, with sensors positioned where the greatest temperature variability is expected. It also recommends high- and low-temperature alarms and states that automated, continuous monitoring is preferable.

Temperature Mapping: Proving the Design Works

One part of the job is building a warehouse to specification. Pharmaceutical warehouse temperature mapping is the study that demonstrates the finished facility actually does maintain the specified temperature conditions throughout the qualified storage volume, not just at the thermostat.

A typical mapping study goes as follows:

1. Scope definition: From the main storage areas to the cold rooms, freezers, quarantine areas, receiving or loading bays, define the spaces in which temperature-sensitive products are stored or handled.
2. Install calibrated sensors throughout the space: The number and location of sensors are based on the risk involved and the size and layout of the warehouse, rather than a fixed grid. Sensor placement should be justified considering shelving, racking, room geometry and known airflow patterns.
3. Conduct the study under representative conditions: For warehouses and other ambient storage areas, WHO guidance typically recommends a minimum of seven consecutive days; for cold rooms and freezer rooms that are not critically affected by ambient temperature variations, the study may run for 24 to 72 hours, or longer if justified. Door-opening or power-failure challenges should be included where required by the approved qualification protocol and risk assessment.
4. Consider seasonal conditions: Where storage areas are affected by seasonal temperature variations, mapping may be needed during the warmest and coldest conditions. WHO guidance notes that two-season mapping is typically not necessary for cold rooms and freezer rooms.
5. Find hot spots and cold spots: Mapping results are used to identify suitable permanent monitoring locations, including areas that experience temperature extremes or represent worst-case conditions. EU GDP similarly states that monitoring equipment should be positioned according to mapping results in areas experiencing extremes of fluctuation.
6. Document everything: The final report should state whether the study met the acceptance criteria and identify the locations of hot and cold spots and any HVAC adjustments that are a result of the findings.
7. Re-mapping is not a one-off occurrence either: The frequency should be based on the monitoring strategy and risk assessment, with WHO giving every three years as one example of periodic mapping, and it should be repeated sooner if the warehouse layout changes, refrigeration or temperature-control systems are modified, storage patterns change materially, or monitoring data indicates unexplained variability.
   
   Know More : World Health Organization

Common Design Mistakes to Avoid

In cold chain warehouse projects that end up in compliance trouble, these patterns show up again and again:

• Making loading docks an afterthought. This is where excursions are more likely to occur because products may be exposed to changing external conditions, and it is difficult to rectify airlock, dock shelter or staging-area shortcomings after construction has progressed.
• Refrigeration capacity is undersized for future growth. Future storage demand can increase or change, and a system designed only for current volume may have limited ability to expand without a costly retrofit.
• Relying only on manual temperature logs. Automated, continuous tracking provides faster excursion detection, consistent data capture and audit-ready records, while manual monitoring depends more heavily on human intervention. WHO guidance states that automated and continuous monitoring is preferable and offers reliability advantages compared with manual measurement.
• Skipping seasonal considerations where they are relevant. If an area is affected by seasonal temperature variation and the mapping study is carried out only under mild conditions, the study may not demonstrate how the space performs under the relevant seasonal extremes.
• Using refrigeration equipment that has not been qualified for its intended use. Suitable equipment must be correctly installed, operated and appropriately qualified to demonstrate that the required storage conditions can be maintained under defined operating conditions. EU GDP requires key equipment and processes to be qualified and/or validated before commencing use, with scope based on documented risk assessment.

Designing for Biologics

The use of biologics makes the design of cold chain warehouses more complicated. Many are more sensitive to temperature excursions than traditional small-molecule drugs, and some require specialised handling for freeze-sensitive formulations, where dropping below the labelled range, even briefly, can be just as damaging as running too warm. In addition to standard vaccines, a biologic facility requires monitoring systems sensitive enough to detect either type of excursion and staff trained to respond according to approved excursion procedures and product-specific stability information.

Bringing It Together at the Design Stage

The performance of a cold chain is strongly influenced at the design stage and should not rely on procedures alone to compensate for engineering design gaps later. Zoning, HVAC and refrigeration capacity, backup power, monitoring infrastructure and control systems need to be designed in concert: a weakness in any one of them can compromise the others. 

Pharma Access partners with pharmaceutical manufacturers on facility design to include these requirements from the outset, including cold storage zoning, HVAC and utility design,BMS/EMS and monitoring integration,  and the CQV work necessary to take a facility through qualification and temperature mapping before it goes live.

If you are a manufacturer thinking about building a new cold storage facility or expanding an existing one, you should consider current and projected storage volumes, the number of temperature zones required, and the level of redundancy appropriate to the product risk, operational continuity requirements and facility strategy.

A Few Final Thoughts

Pharmaceutical cold chain warehouse design isn’t just refrigeration with some added paperwork. It demands meticulous zoning, HVAC engineering within a defined temperature range, and a mapping process that demonstrates the completed building does in fact perform as designed. When these elements are addressed from the start, ongoing GDP compliance becomes more manageable than trying to correct engineering gaps in a facility that was not designed around cold chain requirements.

Frequently Asked Questions

What temperature range do most vaccines and biologics need in storage? 

2°C to 8°C is a common storage range for many vaccines and temperature-sensitive pharmaceutical products. However, storage requirements are product-specific, and some vaccines and biologics require frozen or ultra-cold conditions according to their approved labelling and stability requirements.

How often does a pharmaceutical warehouse need temperature mapping? 

Temperature mapping should be completed before a new temperature-controlled storage area is released for use. Subsequent mapping should be based on the monitoring strategy and risk assessment and should also be repeated following significant changes to the facility, temperature-control equipment or storage arrangement. WHO identifies every three years as an example of a possible periodic interval rather than as a universal requirement.

What is the difference between GMP and GDP for cold chain storage? 

GMP primarily governs pharmaceutical manufacturing and includes controls for storage activities associated with a manufacturing operation, while GDP focuses on maintaining medicinal-product quality throughout storage and distribution in the supply chain. Depending on the function of the facility and the applicable jurisdiction, a pharmaceutical cold storage warehouse may therefore need to satisfy GMP requirements, GDP requirements, or both.

Why are loading docks a common weak point in cold chain warehouses? 

Products are most vulnerable to temperature swings during receiving and shipping when the doors are open and outside air is coming in. Airlock-style anterooms or dock shelters are among the engineering measures that can help limit that exposure, together with appropriate staging, door-control and operating strategies, and it’s difficult to correct such design shortcomings after construction if they were not considered early.

Can an existing warehouse be retrofitted for pharmaceutical cold storage, or does it need to be purpose-built? 

Retrofitting is possible depending on the existing structure of the building, the capacity of the utilities, and the infrastructure of the HVAC system. A facility engineering assessment can determine if a retrofit meets GDP requirements or if a purpose-built facility makes more sense.